CORE--FLUORESCENCE ACTIVATED CELL SORTING (FACS)
CORE--FLUORESCENCE ACTIVATED CELL SORTING (FACS)
批准号:
6237233
负责人:
MICHAEL ANDREEFF
金额:
$15.12万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-27 至 1998-03-31
中文摘要
FACS核心设施为
该计划项目的调查人员。实验室已经提供了
并开发了单细胞分析的尖端技术。
由于这笔赠款的重点是细胞凋亡,TdT-b-dUTP检测
建立并修改了细胞凋亡率(TUNEL)
DNA和BUDR相结合的多参数分析
测量(细胞周期、倍体)、免疫表型分析
祖细胞和血统受限的细胞群体,
与细胞凋亡相关的细胞内蛋白(bcl2、p53、Rb),以及
细胞表面抗原包括Fas和mdr1。最近,绑定了
膜联蛋白V到磷脂酰丝氨酸(PS)被认为是一种检测
在改变之前的膜脂结构的改变
TUNEL法检测细胞凋亡情况。量化:
细胞抗原现在是可用的,使我们能够确定
抗体结合能力(ABC)。细胞动力学变化可以是
宫内节育器和BUDR输注后患者的研究
流式细胞仪分析。荧光原位杂交
(FISH)也与细胞凋亡检测相结合,允许
美国用来区分正常细胞和白血病细胞的凋亡。这个
残留白血病细胞的数量、表型和增殖
(MRD)可进行FISH分析的异常情况
仅在30,000名正常人群中检测出1例白血病
细胞。这项检测可以预测缓解期,并将
适用于诱导治疗后的患者和骨髓
移植。
英文摘要
The FACS Core facility provides cellular analysis to the
investigators of this program project. The laboratory has provided
and developed cutting edge techniques in single cell analysis.
With the focus of this grant on apoptosis, the TdT-b-dUTP assay
for apoptosis (TUNEL) was established and modified for
multiparameter analysis in combination with DNA and BUdR
measurements (cell cycle, ploidy), immunophenotype to analyze
progenitor cells and lineage restricted cell populations,
intracellular proteins related to apoptosis (bcl-2, p53, Rb), and
cell surface antigens including fas and MDR1. Recently, binding of
Annexin V to phosphatidyl serine (PS) was recognized as a test for
changes in the membrane lipid structure that precedes changes
detected by TUNEL in cells undergoing apoptosis. Quantitation of
cellular antigens is now available allowing us to determine the
Antibody Binding Capacity (ABC). Cell kinetic changes can be
studied in patients with infusion of IUdR and BUdR and subsequent
analysis by flow cytometry. Fluorescence in situ hybridization
(FISH) has also been combined with the apoptosis-assays, allowing
us to discriminate apoptosis in normal and leukemic cells. The
number, phenotype and proliferation of residual leukemic cells
(MRD) with abnormalities amenable to FISH analysis can be
determined at levels of as few as 1 leukemic in 30,000 normal
cells. This assay is predictive of remission duration and will be
applied to patients after induction therapy and bone marrow
transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
-
批准号:10356325
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2022
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
-
批准号:10550265
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2022
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
-
批准号:10663157
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2019
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
-
批准号:9806956
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2019
-
负责人:MICHAEL ANDREEFF
-
依托单位:
P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia
-
批准号:8499746
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2013
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
-
批准号:7897533
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
-
批准号:8056055
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Targeting Microenvironment / Leukemia Cell Interactions in CML
-
批准号:8000073
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2010
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Non-genotoxic p53 activation as novel therapeutic concept for lymphoma
-
批准号:7715218
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta
-
批准号:7936811
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta
-
批准号:8324135
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:MICHAEL ANDREEFF
-
依托单位:
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia
-
批准号:7468678
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Flow Cytometry
-
批准号:7695941
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Treatment of Metastatic Breast Cancer with Gene Modified Mesenchymal Stem Cells
-
批准号:7737051
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2008
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Fluorescence-Activated Cell Sorting (FACS) and Molecular Cytogenetics (FISH)
-
批准号:7270271
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2007
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Targeting Regulators of Apoptosis in AML
-
批准号:7270264
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2007
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6649746
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6470779
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
Anti-Leukemic Activity of the Novel Triterpeniod CDDO
-
批准号:6796771
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2002
-
负责人:MICHAEL ANDREEFF
-
依托单位:
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY
-
批准号:6481853
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2001
-
负责人:MICHAEL ANDREEFF
-
依托单位:
海外基金